Bcl-6 (7D1) Antibody sc-130916 from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Bcl-6 (7D1) Antibody

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Bcl-6 (7D1) Antibody

The Bcl-6 (7D1) Antibody from Santa Cruz Biotechnology, Inc. is a Rat Monoclonal antibody to BCL6, and BCL6 transcription repressor. This antibody recognizes Homo Sapiens, Human, Mouse, and Rat antigen. The Bcl-6 (7D1) Antibody has been shown to work in the following applications: Precipitation, Flow Cytometry, Immunofluorescence, Immunoprecipitation, and Western Blot.

Description

Product Type: 604

Gene ID: 12053

Product Specs
ItemBcl-6 (7D1) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-130916
Antibody TypePrimary Antibodies
NCBI Gene AliasesZNF51, LAZ3, Bcl5, BCL5, BCL6A, ZBTB27
Quantity200 µg/ml
Clone7D1
FormatPurified
Conjugate/TagUnconjugated
Reactivitymouse, rat, human
ClonalityMonoclonal
ApplicationsWB, IP, IF, FCM
Hostrat
NCBI Full Gene NameB cell leukemia/lymphoma 6, BCL6 transcription repressor
TargetBcl-6
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Nonredundant Roles of IL-21 and IL-4 in the Phased Initiation of Germinal Center B Cells and Subsequent Self-Renewal TransitionsJournal of immunology (Baltimore, Md. : 1950)December 15, 2018Gonzalez DG, Cote CM, Patel JR, Smith CB, Zhang Y, Nickerson KM, Zhang T, Kerfoot SM, Haberman AM.

(2) Role of Bcl-3 in the development of follicular helper T cells and in the pathogenesis of rheumatoid arthritisArthritis & rheumatology (Hoboken, N.J.)October 1, 2015Meguro K, Suzuki K, Hosokawa J, Sanayama Y, Tanaka S, Furuta S, Ikeda K, Takatori H, Suto A, Sakamoto A, et al.

(3) NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cellsOncology lettersJune 1, 2015Wang X, Jia L, Jin X, Liu Q, Cao W, Gao X, Yang M, Sun B.

(4) Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosisThe Journal of infectious diseasesDecember 15, 2014Vogelzang A, Perdomo C, Zedler U, Kuhlmann S, Hurwitz R, Gengenbacher M, Kaufmann SH.

(5) Low-affinity T cells are programmed to maintain normal primary responses but are impaired in their recall to low-affinity ligandsCell reportsAugust 15, 2013Knudson KM, Goplen NP, Cunningham CA, Daniels MA, Teixeiro E.

(6) IL-6 production by dendritic cells is dispensable for CD8+ memory T-cell generationBioMed research internationalJanuary 1, 2013Daudelin JF, Mathieu M, Boulet S, Labrecque N.

(7) CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cellsPloS oneJanuary 1, 2012Mathieu M, Cotta-Grand N, Daudelin JF, Boulet S, Lapointe R, Labrecque N.

Be the First to Write a Review!